Walleye Capital
ALXO icon

Walleye Capital’s ALX Oncology ALXO Stock Holding History

Walleye Capital’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-230,875
Closed -$420K – 4788
2024
Q3 		$420K Buy
230,875
+121,113
+110% +$450K ﹤0.01% 3459
2024
Q2 		$662K Buy
109,762
+71,521
+187% +$879K ﹤0.01% 3252
2024
Q1 		$426K Sell
38,241
-39,589
-51% -$556K ﹤0.01% 3337
2023
Q4 		$1.16M Buy
+77,830
New +$738K ﹤0.01% 2226
2022
Q1 		– Sell
-58,744
Closed -$1.26M – 2263
2021
Q4 		$1.26M Buy
+58,744
New +$2.53M 0.04% 472

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Walleye Capital's ALXO Position: Q4 2024 in Review

Walleye Capital sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 230,875 shares — an estimated $420K sold.

Walleye Capital first reported a position in ALXO in Q4 2021 and held it in 5 quarters. The position peaked at $1.26M in Q4 2021. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • Walleye Capital reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 230,875 ALX Oncology shares in Q4 2024, an estimated $420K.
  • Walleye Capital first reported a position in ALX Oncology in Q4 2021 and held it in 5 quarters.
  • Walleye Capital's ALX Oncology position peaked at $1.26M in Q4 2021.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.